Tag: posted
J&J’s immunology meds Stelara, Tremfya posted big revenue gains, but pricing...
Johnson & Johnson touted solid growth for its immunology meds Stelara and Tremfya in its latest quarterly results, but Bernstein analysts are spotlighting steep net pricing...
